JOHNSON JOHNSON DE MEXICO supplier risk profile Q1-2026: 124 shipments, 4 suppliers, A-grade assessment.
JOHNSON JOHNSON DE MEXICO imported 124 shipments across 4 suppliers and 4 countries in Q1 2026. The United States dominated sourcing at 70.2% of total volume, primarily through JOHNSON JOHNSON VISION CARE with 87 shipments. Medical devices and optical instruments (HS Chapter 90) accounted for the vast majority of imports, with smaller volumes in pharmaceuticals and electrical components. Ireland and Belgium supplied the remaining 26.8% of shipments through DePuy Ireland and GMED Healthcare.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
The importer registered zero matches on sanctions watchlists and zero suppliers with forced-labor exposure under UFLPA proximity screening. No compliance flags emerged in Q1 2026.
4 distinct tier-1 suppliers in Q1 2026
| JOHNSON JOHNSON VISION CARE | United States | 87 |
| DEPUY IRELAND UC | Ireland | 33 |
| GMED HEALTHCARE BVBA | Belgium | 3 |
| JOHNSON JOHNSON MEDTECH COLOMBIA | Colombia | 1 |
Share of Q1 2026 inbound shipments by source country
0 tier-2 + 0 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.